ICON plc
A Global Study Lead in Oncology is responsible for end-to-end design, execution, and reporting of clinical trials, with leadership in project teams and across matrix teams, ensuring studies are delivered on time, quality, budget, and to company standards.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
9% above the average for this role
Global Trial Associate
Bristol Myers Squibb
Global Study Director Cell Therapy
AstraZeneca
Global Trial Lead
Bristol Myers Squibb
Local Study Associate Director Oncology Macquarie Park New South Wales Australia
AstraZeneca
Senior Clinical Trial Manager Electrophysiology Arden Hills Us Mn United States Us Ma Marlborough Us Mn Arden Hills Us Ga Johns Creek
bostonscientific
Clinical Trial Manager
Precision for Medicine